Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Gross Profit: 2010-2024

Historic Gross Profit for Kura Oncology (KURA) over the last 14 years, with Dec 2024 value amounting to $53.9 million.

  • Kura Oncology's Gross Profit rose 5136.41% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year change of. This contributed to the annual value of $53.9 million for FY2024, which is 3578.57% up from last year.
  • Latest data reveals that Kura Oncology reported Gross Profit of $53.9 million as of FY2024, which was up 3,578.57% from -$1.5 million recorded in FY2023.
  • Kura Oncology's 5-year Gross Profit high stood at $53.9 million for FY2024, and its period low was -$1.5 million during FY2023.
  • Moreover, its 3-year median value for Gross Profit was -$229,000 (2022), whereas its average is $17.4 million.
  • Its Gross Profit has fluctuated over the past 5 years, first tumbled by 576.42% in 2023, then skyrocketed by 3,578.57% in 2024.
  • Kura Oncology's Gross Profit (Yearly) stood at -$578,000 in 2020, then grew by 28.37% to -$414,000 in 2021, then soared by 44.69% to -$229,000 in 2022, then plummeted by 576.42% to -$1.5 million in 2023, then skyrocketed by 3,578.57% to $53.9 million in 2024.